APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medicated Confectionery

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medicated Confectionery Market Outlook and Growth Opportunities 2026

5 July 2026203 pages

Choose your research edition.

Industry ResearchMedicated Confectionery Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Medicated Confectionery Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Medicated Confectionery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medicated Confectionery Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Medicated Confectionery Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Medicated Confectionery market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medicated Confectionery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medicated Confectionery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medicated Confectionery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medicated Confectionery market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medicated Confectionery market include Perfetti Van Melle (Halls), Reckitt Benckiser (Strepsils), Ricola AG, Jakemans, Wrigley Company, Mondelez International (Ernest Jackson), Nestle, Procter & Gamble and Meda Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Medicated Confectionery market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medicated Confectionery and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medicated Confectionery sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medicated Confectionery market size, projected growth trends, production technologies, key applications, and end-use industries.

Medicated Confectionery Segment by Company

Perfetti Van Melle (Halls)

Reckitt Benckiser (Strepsils)

Ricola AG

Jakemans

Wrigley Company

Mondelez International (Ernest Jackson)

Nestle

Procter & Gamble

Meda Pharmaceuticals

UHA Mikakuto

Herbion International

HEXOS

Lofthouse of Fleetwood

Läkerol

Luden's

Olbas

Baker Perkins Limited

Medicated Confectionery Segment by Type

Lozenges

Chewable Tablets

Gummy

Other

Medicated Confectionery Segment by Application

Pharmacies/Drugstores

Supermarkets/Convenience Stores

Health & Wellness Stores

Hospital/Clinic Pharmacies

Online Retailers

Medicated Confectionery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medicated Confectionery status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Medicated Confectionery market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medicated Confectionery significant trends, drivers, influence factors in global and regions.

6. To analyze Medicated Confectionery competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medicated Confectionery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medicated Confectionery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medicated Confectionery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Medicated Confectionery market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medicated Confectionery industry.

Chapter 3: Detailed analysis of Medicated Confectionery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Medicated Confectionery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Medicated Confectionery in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medicated Confectionery Industry Trends Table 2. Medicated Confectionery Industry Drivers Table 3. Medicated Confectionery Industry Opportunities and Challenges Table 4. Medicated Confectionery Industry Restraints Table 5. Global Medicated Confectionery Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medicated Confectionery Revenue Share by Company (2021-2026) Table 7. Global Medicated Confectionery Sales Volume by Company (kt) & (2021-2026) Table 8. Global Medicated Confectionery Sales Volume Share by Company (2021-2026) Table 9. Global Medicated Confectionery Average Price (USD/t) of Company (2021-2026) Table 10. Global Medicated Confectionery Company Ranking, (2024-2026) & (USD Million) Table 11. Global Medicated Confectionery Key Company Manufacturing Base & Headquarters Table 12. Global Medicated Confectionery Company, Product Type & Application Table 13. Global Medicated Confectionery Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Medicated Confectionery by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Lozenges Table 18. Significant Companies of Chewable Tablets Table 19. Significant Companies of Gummy Table 20. Significant Companies of Other Table 21. Global Medicated Confectionery Sales Volume by Type 2021 VS 2025 VS 2032 (kt) Table 22. Global Medicated Confectionery Sales Volume by Type (2021-2026) & (kt) Table 23. Global Medicated Confectionery Sales Volume by Type (2027-2032) & (kt) Table 24. Global Medicated Confectionery Sales Volume Share by Type (2021-2026) Table 25. Global Medicated Confectionery Sales Volume Share by Type (2027-2032) Table 26. Global Medicated Confectionery Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Medicated Confectionery Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Medicated Confectionery Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Medicated Confectionery Sales Value Share by Type (2021-2026) Table 30. Global Medicated Confectionery Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Pharmacies/Drugstores Table 32. Significant Companies of Supermarkets/Convenience Stores Table 33. Significant Companies of Health & Wellness Stores Table 34. Significant Companies of Hospital/Clinic Pharmacies Table 35. Significant Companies of Online Retailers Table 36. Global Medicated Confectionery Sales Volume by Application 2021 VS 2025 VS 2032 (kt) Table 37. Global Medicated Confectionery Sales Volume by Application (2021-2026) & (kt) Table 38. Global Medicated Confectionery Sales Volume by Application (2027-2032) & (kt) Table 39. Global Medicated Confectionery Sales Volume Share by Application (2021-2026) Table 40. Global Medicated Confectionery Sales Volume Share by Application (2027-2032) Table 41. Global Medicated Confectionery Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Medicated Confectionery Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Medicated Confectionery Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Medicated Confectionery Sales Value Share by Application (2021-2026) Table 45. Global Medicated Confectionery Sales Value Share by Application (2027-2032) Table 46. Global Medicated Confectionery Sales by Region: 2021 VS 2025 VS 2032 (kt) Table 47. Global Medicated Confectionery Sales by Region (2021-2026) & (kt) Table 48. Global Medicated Confectionery Sales Market Share by Region (2021-2026) Table 49. Global Medicated Confectionery Sales by Region (2027-2032) & (kt) Table 50. Global Medicated Confectionery Sales Market Share by Region (2027-2032) Table 51. Global Medicated Confectionery Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Medicated Confectionery Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Medicated Confectionery Sales Value Share by Region (2021-2026) Table 54. Global Medicated Confectionery Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Medicated Confectionery Sales Value Share by Region (2027-2032) Table 56. Global Medicated Confectionery Market Average Price (USD/t) by Region (2021-2026) Table 57. Global Medicated Confectionery Market Average Price (USD/t) by Region (2027-2032) Table 58. Global Medicated Confectionery Sales by Country: 2021 VS 2025 VS 2032 (kt) Table 59. Global Medicated Confectionery Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Medicated Confectionery Sales by Country (2021-2026) & (kt) Table 61. Global Medicated Confectionery Sales Market Share by Country (2021-2026) Table 62. Global Medicated Confectionery Sales by Country (2027-2032) & (kt) Table 63. Global Medicated Confectionery Sales Market Share by Country (2027-2032) Table 64. Global Medicated Confectionery Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Medicated Confectionery Sales Value Market Share by Country (2021-2026) Table 66. Global Medicated Confectionery Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Medicated Confectionery Sales Value Market Share by Country (2027-2032) Table 68. Perfetti Van Melle (Halls) Company Information Table 69. Perfetti Van Melle (Halls) Business Overview Table 70. Perfetti Van Melle (Halls) Medicated Confectionery Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 71. Perfetti Van Melle (Halls) Medicated Confectionery Product Portfolio Table 72. Perfetti Van Melle (Halls) Recent Development Table 73. Reckitt Benckiser (Strepsils) Company Information Table 74. Reckitt Benckiser (Strepsils) Business Overview Table 75. Reckitt Benckiser (Strepsils) Medicated Confectionery Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 76. Reckitt Benckiser (Strepsils) Medicated Confectionery Product Portfolio Table 77. Reckitt Benckiser (Strepsils) Recent Development Table 78. Ricola AG Company Information Table 79. Ricola AG Business Overview Table 80. Ricola AG Medicated Confectionery Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 81. Ricola AG Medicated Confectionery Product Portfolio Table 82. Ricola AG Recent Development Table 83. Jakemans Company Information Table 84. Jakemans Business Overview Table 85. Jakemans Medicated Confectionery Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 86. Jakemans Medicated Confectionery Product Portfolio Table 87. Jakemans Recent Development Table 88. Wrigley Company Company Information Table 89. Wrigley Company Business Overview Table 90. Wrigley Company Medicated Confectionery Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 91. Wrigley Company Medicated Confectionery Product Portfolio Table 92. Wrigley Company Recent Development Table 93. Mondelez International (Ernest Jackson) Company Information Table 94. Mondelez International (Ernest Jackson) Business Overview Table 95. Mondelez International (Ernest Jackson) Medicated Confectionery Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 96. Mondelez International (Ernest Jackson) Medicated Confectionery Product Portfolio Table 97. Mondelez International (Ernest Jackson) Recent Development Table 98. Nestle Company Information Table 99. Nestle Business Overview Table 100. Nestle Medicated Confectionery Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 101. Nestle Medicated Confectionery Product Portfolio Table 102. Nestle Recent Development Table 103. Procter & Gamble Company Information Table 104. Procter & Gamble Business Overview Table 105. Procter & Gamble Medicated Confectionery Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 106. Procter & Gamble Medicated Confectionery Product Portfolio Table 107. Procter & Gamble Recent Development Table 108. Meda Pharmaceuticals Company Information Table 109. Meda Pharmaceuticals Business Overview Table 110. Meda Pharmaceuticals Medicated Confectionery Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 111. Meda Pharmaceuticals Medicated Confectionery Product Portfolio Table 112. Meda Pharmaceuticals Recent Development Table 113. UHA Mikakuto Company Information Table 114. UHA Mikakuto Business Overview Table 115. UHA Mikakuto Medicated Confectionery Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 116. UHA Mikakuto Medicated Confectionery Product Portfolio Table 117. UHA Mikakuto Recent Development Table 118. Herbion International Company Information Table 119. Herbion International Business Overview Table 120. Herbion International Medicated Confectionery Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 121. Herbion International Medicated Confectionery Product Portfolio Table 122. Herbion International Recent Development Table 123. HEXOS Company Information Table 124. HEXOS Business Overview Table 125. HEXOS Medicated Confectionery Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 126. HEXOS Medicated Confectionery Product Portfolio Table 127. HEXOS Recent Development Table 128. Lofthouse of Fleetwood Company Information Table 129. Lofthouse of Fleetwood Business Overview Table 130. Lofthouse of Fleetwood Medicated Confectionery Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 131. Lofthouse of Fleetwood Medicated Confectionery Product Portfolio Table 132. Lofthouse of Fleetwood Recent Development Table 133. Läkerol Company Information Table 134. Läkerol Business Overview Table 135. Läkerol Medicated Confectionery Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 136. Läkerol Medicated Confectionery Product Portfolio Table 137. Läkerol Recent Development Table 138. Luden's Company Information Table 139. Luden's Business Overview Table 140. Luden's Medicated Confectionery Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 141. Luden's Medicated Confectionery Product Portfolio Table 142. Luden's Recent Development Table 143. Olbas Company Information Table 144. Olbas Business Overview Table 145. Olbas Medicated Confectionery Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 146. Olbas Medicated Confectionery Product Portfolio Table 147. Olbas Recent Development Table 148. Baker Perkins Limited Company Information Table 149. Baker Perkins Limited Business Overview Table 150. Baker Perkins Limited Medicated Confectionery Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 151. Baker Perkins Limited Medicated Confectionery Product Portfolio Table 152. Baker Perkins Limited Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Medicated Confectionery Distributors List Table 156. Medicated Confectionery Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Medicated Confectionery Product Image Figure 2. Global Medicated Confectionery Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medicated Confectionery Sales Value (2021-2032) & (US$ Million) Figure 4. Global Medicated Confectionery Sales (2021-2032) & (kt) Figure 5. Global Medicated Confectionery Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Medicated Confectionery Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Lozenges Image Figure 10. Chewable Tablets Image Figure 11. Gummy Image Figure 12. Other Image Figure 13. Global Medicated Confectionery Sales Volume by Type (2021 VS 2025 VS 2032) & (kt) Figure 14. Global Medicated Confectionery Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Medicated Confectionery Sales Volume Share by Type (2021-2032) Figure 16. Global Medicated Confectionery Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Medicated Confectionery Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Medicated Confectionery Sales Value Share by Type (2021-2032) Figure 19. Pharmacies/Drugstores Image Figure 20. Supermarkets/Convenience Stores Image Figure 21. Health & Wellness Stores Image Figure 22. Hospital/Clinic Pharmacies Image Figure 23. Online Retailers Image Figure 24. Global Medicated Confectionery Sales Volume by Application (2021 VS 2025 VS 2032) & (kt) Figure 25. Global Medicated Confectionery Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Medicated Confectionery Sales Volume Share by Application (2021-2032) Figure 27. Global Medicated Confectionery Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Medicated Confectionery Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Medicated Confectionery Sales Value Share by Application (2021-2032) Figure 30. Global Medicated Confectionery Sales by Region: 2021 VS 2025 VS 2032 (kt) Figure 31. Global Medicated Confectionery Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Medicated Confectionery Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Medicated Confectionery Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Medicated Confectionery Sales Value (2021-2032) & (US$ Million) Figure 35. North America Medicated Confectionery Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Medicated Confectionery Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Medicated Confectionery Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Medicated Confectionery Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Medicated Confectionery Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Medicated Confectionery Sales Value (2021-2032) & (US$ Million) Figure 41. South America Medicated Confectionery Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Medicated Confectionery Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Medicated Confectionery Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Medicated Confectionery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Medicated Confectionery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Medicated Confectionery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Medicated Confectionery Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Medicated Confectionery Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Lozenges
  • Chewable Tablets
  • Gummy
  • Other
Applications
  • Pharmacies/Drugstores
  • Supermarkets/Convenience Stores
  • Health & Wellness Stores
  • Hospital/Clinic Pharmacies
  • Online Retailers
Companies covered
  • Perfetti Van Melle (Halls)
  • Reckitt Benckiser (Strepsils)
  • Ricola AG
  • Jakemans
  • Wrigley Company
  • Mondelez International (Ernest Jackson)
  • Nestle
  • Procter & Gamble
  • Meda Pharmaceuticals
  • UHA Mikakuto
  • Herbion International
  • HEXOS
  • Lofthouse of Fleetwood
  • Läkerol
  • Luden's
  • Olbas
  • Baker Perkins Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Medicated Confectionery Sales Value (2021-2032)
  4. 1.2.2 Global Medicated Confectionery Sales Volume (2021-2032)
  5. 1.2.3 Global Medicated Confectionery Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Medicated Confectionery Market Dynamics
  1. 2.1 Medicated Confectionery Industry Trends
  2. 2.2 Medicated Confectionery Industry Drivers
  3. 2.3 Medicated Confectionery Industry Opportunities and Challenges
  4. 2.4 Medicated Confectionery Industry Restraints
3 Medicated Confectionery Market by Company
  1. 3.1 Global Medicated Confectionery Company Revenue Ranking in 2025
  2. 3.2 Global Medicated Confectionery Revenue by Company (2021-2026)
  3. 3.3 Global Medicated Confectionery Sales Volume by Company (2021-2026)
  4. 3.4 Global Medicated Confectionery Average Price by Company (2021-2026)
  5. 3.5 Global Medicated Confectionery Company Ranking (2024-2026)
  6. 3.6 Global Medicated Confectionery Company Manufacturing Base and Headquarters
  7. 3.7 Global Medicated Confectionery Company Product Type and Application
  8. 3.8 Global Medicated Confectionery Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Medicated Confectionery Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Medicated Confectionery Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Medicated Confectionery Market by Type
  1. 4.1 Medicated Confectionery Type Introduction
  2. 4.1.1 Lozenges
  3. 4.1.2 Chewable Tablets
  4. 4.1.3 Gummy
  5. 4.1.4 Other
  6. 4.2 Global Medicated Confectionery Sales Volume by Type
  7. 4.2.1 Global Medicated Confectionery Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Medicated Confectionery Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Medicated Confectionery Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Medicated Confectionery Sales Value by Type
  11. 4.3.1 Global Medicated Confectionery Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Medicated Confectionery Sales Value by Type (2021-2032)
  13. 4.3.3 Global Medicated Confectionery Sales Value Share by Type (2021-2032)
5 Medicated Confectionery Market by Application
  1. 5.1 Medicated Confectionery Application Introduction
  2. 5.1.1 Pharmacies/Drugstores
  3. 5.1.2 Supermarkets/Convenience Stores
  4. 5.1.3 Health & Wellness Stores
  5. 5.1.4 Hospital/Clinic Pharmacies
  6. 5.1.5 Online Retailers
  7. 5.2 Global Medicated Confectionery Sales Volume by Application
  8. 5.2.1 Global Medicated Confectionery Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Medicated Confectionery Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Medicated Confectionery Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Medicated Confectionery Sales Value by Application
  12. 5.3.1 Global Medicated Confectionery Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Medicated Confectionery Sales Value by Application (2021-2032)
  14. 5.3.3 Global Medicated Confectionery Sales Value Share by Application (2021-2032)
6 Medicated Confectionery Regional Sales and Value Analysis
  1. 6.1 Global Medicated Confectionery Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medicated Confectionery Sales by Region (2021-2032)
  3. 6.2.1 Global Medicated Confectionery Sales by Region: 2021-2026
  4. 6.2.2 Global Medicated Confectionery Sales by Region (2027-2032)
  5. 6.3 Global Medicated Confectionery Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Medicated Confectionery Sales Value by Region (2021-2032)
  7. 6.4.1 Global Medicated Confectionery Sales Value by Region: 2021-2026
  8. 6.4.2 Global Medicated Confectionery Sales Value by Region (2027-2032)
  9. 6.5 Global Medicated Confectionery Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Medicated Confectionery Sales Value (2021-2032)
  12. 6.6.2 North America Medicated Confectionery Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Medicated Confectionery Sales Value (2021-2032)
  15. 6.7.2 Europe Medicated Confectionery Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Medicated Confectionery Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Medicated Confectionery Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Medicated Confectionery Sales Value (2021-2032)
  21. 6.9.2 South America Medicated Confectionery Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Medicated Confectionery Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Medicated Confectionery Sales Value Share by Country, 2025 VS 2032
7 Medicated Confectionery Country-level Sales and Value Analysis
  1. 7.1 Global Medicated Confectionery Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medicated Confectionery Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Medicated Confectionery Sales by Country (2021-2032)
  4. 7.3.1 Global Medicated Confectionery Sales by Country (2021-2026)
  5. 7.3.2 Global Medicated Confectionery Sales by Country (2027-2032)
  6. 7.4 Global Medicated Confectionery Sales Value by Country (2021-2032)
  7. 7.4.1 Global Medicated Confectionery Sales Value by Country (2021-2026)
  8. 7.4.2 Global Medicated Confectionery Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Medicated Confectionery Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Medicated Confectionery Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Medicated Confectionery Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Medicated Confectionery Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Medicated Confectionery Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Medicated Confectionery Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Medicated Confectionery Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Medicated Confectionery Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Medicated Confectionery Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Medicated Confectionery Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Medicated Confectionery Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Medicated Confectionery Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Medicated Confectionery Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Medicated Confectionery Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Medicated Confectionery Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Medicated Confectionery Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Medicated Confectionery Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Medicated Confectionery Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Medicated Confectionery Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Medicated Confectionery Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Medicated Confectionery Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Medicated Confectionery Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Medicated Confectionery Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Medicated Confectionery Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Medicated Confectionery Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Medicated Confectionery Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Medicated Confectionery Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Medicated Confectionery Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Medicated Confectionery Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Medicated Confectionery Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Perfetti Van Melle (Halls)
  2. 8.1.1 Perfetti Van Melle (Halls) Company Information
  3. 8.1.2 Perfetti Van Melle (Halls) Business Overview
  4. 8.1.3 Perfetti Van Melle (Halls) Medicated Confectionery Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Perfetti Van Melle (Halls) Medicated Confectionery Product Portfolio
  6. 8.1.5 Perfetti Van Melle (Halls) Recent Developments
  7. 8.2 Reckitt Benckiser (Strepsils)
  8. 8.2.1 Reckitt Benckiser (Strepsils) Company Information
  9. 8.2.2 Reckitt Benckiser (Strepsils) Business Overview
  10. 8.2.3 Reckitt Benckiser (Strepsils) Medicated Confectionery Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Reckitt Benckiser (Strepsils) Medicated Confectionery Product Portfolio
  12. 8.2.5 Reckitt Benckiser (Strepsils) Recent Developments
  13. 8.3 Ricola AG
  14. 8.3.1 Ricola AG Company Information
  15. 8.3.2 Ricola AG Business Overview
  16. 8.3.3 Ricola AG Medicated Confectionery Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Ricola AG Medicated Confectionery Product Portfolio
  18. 8.3.5 Ricola AG Recent Developments
  19. 8.4 Jakemans
  20. 8.4.1 Jakemans Company Information
  21. 8.4.2 Jakemans Business Overview
  22. 8.4.3 Jakemans Medicated Confectionery Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Jakemans Medicated Confectionery Product Portfolio
  24. 8.4.5 Jakemans Recent Developments
  25. 8.5 Wrigley Company
  26. 8.5.1 Wrigley Company Company Information
  27. 8.5.2 Wrigley Company Business Overview
  28. 8.5.3 Wrigley Company Medicated Confectionery Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Wrigley Company Medicated Confectionery Product Portfolio
  30. 8.5.5 Wrigley Company Recent Developments
  31. 8.6 Mondelez International (Ernest Jackson)
  32. 8.6.1 Mondelez International (Ernest Jackson) Company Information
  33. 8.6.2 Mondelez International (Ernest Jackson) Business Overview
  34. 8.6.3 Mondelez International (Ernest Jackson) Medicated Confectionery Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mondelez International (Ernest Jackson) Medicated Confectionery Product Portfolio
  36. 8.6.5 Mondelez International (Ernest Jackson) Recent Developments
  37. 8.7 Nestle
  38. 8.7.1 Nestle Company Information
  39. 8.7.2 Nestle Business Overview
  40. 8.7.3 Nestle Medicated Confectionery Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nestle Medicated Confectionery Product Portfolio
  42. 8.7.5 Nestle Recent Developments
  43. 8.8 Procter & Gamble
  44. 8.8.1 Procter & Gamble Company Information
  45. 8.8.2 Procter & Gamble Business Overview
  46. 8.8.3 Procter & Gamble Medicated Confectionery Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Procter & Gamble Medicated Confectionery Product Portfolio
  48. 8.8.5 Procter & Gamble Recent Developments
  49. 8.9 Meda Pharmaceuticals
  50. 8.9.1 Meda Pharmaceuticals Company Information
  51. 8.9.2 Meda Pharmaceuticals Business Overview
  52. 8.9.3 Meda Pharmaceuticals Medicated Confectionery Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Meda Pharmaceuticals Medicated Confectionery Product Portfolio
  54. 8.9.5 Meda Pharmaceuticals Recent Developments
  55. 8.10 UHA Mikakuto
  56. 8.10.1 UHA Mikakuto Company Information
  57. 8.10.2 UHA Mikakuto Business Overview
  58. 8.10.3 UHA Mikakuto Medicated Confectionery Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 UHA Mikakuto Medicated Confectionery Product Portfolio
  60. 8.10.5 UHA Mikakuto Recent Developments
  61. 8.11 Herbion International
  62. 8.11.1 Herbion International Company Information
  63. 8.11.2 Herbion International Business Overview
  64. 8.11.3 Herbion International Medicated Confectionery Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Herbion International Medicated Confectionery Product Portfolio
  66. 8.11.5 Herbion International Recent Developments
  67. 8.12 HEXOS
  68. 8.12.1 HEXOS Company Information
  69. 8.12.2 HEXOS Business Overview
  70. 8.12.3 HEXOS Medicated Confectionery Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 HEXOS Medicated Confectionery Product Portfolio
  72. 8.12.5 HEXOS Recent Developments
  73. 8.13 Lofthouse of Fleetwood
  74. 8.13.1 Lofthouse of Fleetwood Company Information
  75. 8.13.2 Lofthouse of Fleetwood Business Overview
  76. 8.13.3 Lofthouse of Fleetwood Medicated Confectionery Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Lofthouse of Fleetwood Medicated Confectionery Product Portfolio
  78. 8.13.5 Lofthouse of Fleetwood Recent Developments
  79. 8.14 Läkerol
  80. 8.14.1 Läkerol Company Information
  81. 8.14.2 Läkerol Business Overview
  82. 8.14.3 Läkerol Medicated Confectionery Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Läkerol Medicated Confectionery Product Portfolio
  84. 8.14.5 Läkerol Recent Developments
  85. 8.15 Luden's
  86. 8.15.1 Luden's Company Information
  87. 8.15.2 Luden's Business Overview
  88. 8.15.3 Luden's Medicated Confectionery Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Luden's Medicated Confectionery Product Portfolio
  90. 8.15.5 Luden's Recent Developments
  91. 8.16 Olbas
  92. 8.16.1 Olbas Company Information
  93. 8.16.2 Olbas Business Overview
  94. 8.16.3 Olbas Medicated Confectionery Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Olbas Medicated Confectionery Product Portfolio
  96. 8.16.5 Olbas Recent Developments
  97. 8.17 Baker Perkins Limited
  98. 8.17.1 Baker Perkins Limited Company Information
  99. 8.17.2 Baker Perkins Limited Business Overview
  100. 8.17.3 Baker Perkins Limited Medicated Confectionery Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Baker Perkins Limited Medicated Confectionery Product Portfolio
  102. 8.17.5 Baker Perkins Limited Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Medicated Confectionery Value Chain Analysis
  2. 9.1.1 Medicated Confectionery Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Medicated Confectionery Sales Mode & Process
  6. 9.2 Medicated Confectionery Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Medicated Confectionery Distributors
  9. 9.2.3 Medicated Confectionery Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst